查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1470428

心臟标记物市场：按产品、生物标记类型、最终用户、适应症 - 全球预测 2024-2030

Cardiac Marker Market by Product (Instruments, Reagents & Kits), Biomarker Type (BNP Or NT-ProBNP, CK-MB, Hs-CRP), End-User, Indication - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

心臟标记物市场规模预计2023年为38.1亿美元，预计2024年将达到41.6亿美元，2030年将达到72.9亿美元，复合年增长率为9.71%。

心臟标记是在血液中测量的物质或分子，用于诊断和监测各种心臟状况，特别是与心肌损伤和压力相关的状况。这些标记物通常用于医院和实验室等临床环境中，以帮助心血管疾病的诊断、预后和监测。尤其广泛应用于心肌梗塞和其他急性冠状动脉症候群的诊断。心血管疾病（CVD）准确、早期诊断的重要性日益增加，心臟标记市场的评估也逐渐提高。心血管疾病盛行率的上升和全球老年人口的增加正在推动心臟标记的市场需求。对照护现场检测的需求不断增长，医疗基础设施（包括设备齐全的实验室和训练有素的人员）的稳定发展正在推动全球产业的成长。然而，与心血管手术和解决方案相关的高价格正在影响市场采用。生物医学行业的进步，特别是诊断技术的进步，以及旨在促进预防性医疗保健的政府医疗保健倡议和计划，正在帮助扩大对心臟标誌物的需求，并为市场创造巨大的增长机会。

主要市场统计
基准年[2023] 38.1亿美元
预测年份 [2024] 41.6亿美元
预测年份 [2030] 72.9亿美元
复合年增长率（%） 9.71%

产品：试剂和套件提供心臟特异性蛋白质的定性和定量评估

化学发光免疫测量(CLIA) 系统是先进的诊断仪器，可侦测敏感的心臟标记物，如肌钙蛋白、CK-MB 和肌红蛋白。这些装置利用发光基材，在目标抗原存在的情况下与特定酵素反应时发光。酵素结合免疫吸附检测法(ELISA)套件和设备对于心臟标记的检测和定量至关重要。这些测定依赖于产生可测量的比色变化的酶结合反应。 ELISA 系统在可扩展性方面非常弹性，并以其特异性和高灵敏度而闻名。免疫层析法是一种快速简单的诊断技术，利用颗粒透过毛细管作用沿着膜移动。抗体和抗原用于检测特定的生物标记物，例如心臟标记。萤光是一种使用萤光染料或标记物来检测特定抗体或抗原是否存在的技术，用于对心臟标记物进行更详细和特异性的分析。用于心臟标记检测的试剂和套件由针对各种分析平台优化的多种免疫测量组成。这些消耗品通常包括专为心臟特异性蛋白质的定性和定量评估而设计的抗体、抗原、缓衝液和基材。

生物标记类型：BNP 和 NT-proBNP 生物标记在心臟衰竭诊断和治疗中的采用率很高

BNP 和 NT-proBNP 是诊断和治疗心臟衰竭的生物标记。 BNP 从心室肌肉细胞中排放，以应对心臟衰竭典型的体液超负荷导致的室壁张力增加。当这些胜肽被检测到低水平时，它们对心臟风险和心臟衰竭具有强烈的阴性预测价值。相反，高水平表明不良心血管事件的风险增加。肌酸激酶-MB（CK-MB）是肌酸激酶（CK）的同功异构酵素，是诊断心肌梗塞（MI）的传统生物标记之一。它主要存在于心肌细胞中，当心肌细胞死亡时，其在血液中增加。高敏性C反应蛋白（Hs-CRP）是一种急性时相蛋白，也是一种指示全身性发炎的特异性发炎生物标记。它通常用于评估心臟疾病和其他心臟危险因素的风险。肌红蛋白是心肌损伤的早期标记物，但不具有特异性。它与更特异性的心臟标记（例如肌钙蛋白）结合使用最有用，可用于心肌梗塞的早期评估。肌钙蛋白 I 和 T 是调节蛋白，是心肌收缩装置的一部分，是心肌损伤的高度特异性和敏感的生物标记。

最终用户：在测试设施中更多地使用心臟标记物

实验室测试设施通常拥有先进的设备和熟练的员工，可以进行全面的测试。医院和独立诊断实验室是该细分市场的主要组成部分。他们提供准确、大容量的心臟标记检测服务，这对于诊断各种心血管疾病至关重要，包括心肌梗塞（心臟病发作）和急性冠状动脉症候群。即时护理 (POC) 检测设施包括急诊室、救护车、诊所和医生办公室。即时结果有助于快速做出临床决策，对于心臟紧急情况的处理至关重要。肌钙蛋白、BNP（B 型利钠胜肽）和 D-二聚体等心臟标记的 POC 检测彻底改变了心血管疾病的诊断和管理。心臟标记 POCT 系统设计简单、快速，可缩短急诊护理环境中决策的周转时间。

采用心臟标记物治疗郁血性心臟衰竭的可能性

在郁血性心臟衰竭（CHF）中，心臟标记对于诊断、预后和治疗非常重要。 B 型利钠胜肽(BNP) 和 N 端 BNP 前体 (NT-proBNP) 是用于确认疑似 CHF、将其与呼吸困难的其他原因区分开并评估严重程度的主要分子。 BNP 或 NT-proBNP 升高与心臟衰竭相关，这些标记可用于 CHF 患者的诊断和监测。在心肌梗塞 (MI) 中，肌钙蛋白 I、肌钙蛋白 T 和肌酸激酶 MB (CK-MB) 常被用作心肌梗塞的心臟标记。肌钙蛋白是检测心肌损伤的敏感且特异性的标记物。肌钙蛋白升高表示心肌梗塞，有助于诊断急性冠状动脉症候群。

区域洞察

美洲由于心血管疾病盛行率高、医疗设施发达、市场参与企业众多，市场格局显着。心臟病发病率的增加以及对早期诊断和早期治疗的强烈兴趣正在推动该地区对心臟标记检测的需求。此外，生物技术领域的进步和新型诊断技术的高采用率也促进了美国心臟标记市场的成长。欧洲心臟标记市场的成长是由更容易患心臟疾病等慢性疾病的人口老化所推动的。最先进的医疗设施、不断上涨的医疗成本以及有利的监管政策也支持了欧洲心臟标记市场的成长。此外，在心臟生物标记领域，多个主要市场参与企业和持续的研究活动正在进一步刺激市场成长。预计亚太地区心臟标记市场在预测期内将呈现显着成长。这是由于新兴经济体人口基数大、文明病盛行率上升以及医疗基础设施改善缓慢。

FPNV定位矩阵

FPNV定位矩阵对于评估心臟标记市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场占有率分析

市场占有率分析是一种综合工具，可以对心臟标记物市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该细分市场竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：包括新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：包括对未来技术、研发活动和突破性产品开发的智力见解。

本报告解决了以下关键问题：

1.心臟标记物市场的市场规模与预测是多少？

2.在心臟标记物市场预测期内，我们应该考虑投资哪些产品和应用？

3.心臟标记市场的技术趋势和法规结构是什么？

4.心臟标记市场主要厂商的市场占有率是多少？

5. 进入心臟标记物市场的合适形式和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病发生率增加
      • 获得各种心臟生物标记试剂和套件
      • 改善各国的卫生基础设施和支出
    • 抑制因素
      • 与心血管手术和治疗相关的高价格
    • 机会
      • 心臟标记的持续进步
      • 不断改进照护现场解决方案的性质
    • 任务
      • 心臟标誌物的严格法规和核准
  • 市场区隔分析
    • 产品：提供心臟特异性蛋白质定性和定量评估的试剂和套件
    • 生物标记类型：BNP 和 NT-proBNP 生物标记在心臟衰竭诊断和治疗中的采用率较高
    • 最终用户：实验室测试设施中心臟标记物的关键使用
    • 适应症：心臟标记在郁血性心臟衰竭的潜在应用
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章心臟标记市场：副产品

  • 介绍
  • 装置
  • 试剂和套件

第七章心臟标记市场：依生物标记类型

  • 介绍
  • BNP 或 NT-ProBNP
  • CK-MB
  • Hs-CRP
  • 肌红蛋白
  • 肌钙蛋白 I 和 T

第八章心臟标记物市场：依最终用户分类

  • 介绍
  • 实验室测试设施
  • 照护现场侦测设施

第九章心臟标记市场：依适应症分类

  • 介绍
  • 心臟衰竭性郁血性
  • 心肌梗塞

第10章美洲心臟标记物市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太心臟标记物市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲心臟标记市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-034230D3E2D1

[189 Pages Report] The Cardiac Marker Market size was estimated at USD 3.81 billion in 2023 and expected to reach USD 4.16 billion in 2024, at a CAGR 9.71% to reach USD 7.29 billion by 2030.

Cardiac markers are substances or molecules measured in the blood to diagnose and monitor various cardiac conditions, particularly those related to heart muscle damage or stress. These markers are often used in clinical settings, such as hospitals and laboratories, to assist in diagnosing, prognosis, and monitoring cardiovascular diseases. They are particularly widely used in the diagnosis of conditions such as myocardial infarction and other forms of acute coronary syndrome. With an increased emphasis on accurate and early diagnosis in cases of cardiovascular diseases (CVD), the cardiac markers market's valuation has been progressively escalating. The rising incidence of cardiovascular conditions and the growing global geriatric population fuel the market demand for cardiac markers. Rising demand for point-of-care testing and the steady development in healthcare infrastructure, including well-equipped labs and trained personnel, globally aids the industry's growth. However, High prices associated with cardiovascular procedures and solutions affect market adoption. The evolution of the biomedical industry, particularly diagnostic technologies, and government healthcare initiatives and programs aiming to foster preventative care are instrumental in escalating the demand for cardiac markers and creating a significant growth opportunity for the market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.81 billion
Estimated Year [2024] USD 4.16 billion
Forecast Year [2030] USD 7.29 billion
CAGR (%) 9.71%

Product: Reagents and kits provide qualitative and quantitative assessment of cardiac-specific proteins

Chemiluminescence immunoassay (CLIA) systems are sophisticated diagnostic instruments that detect high-sensitivity cardiac markers such as troponin, CK-MB, and myoglobin. These instruments utilize luminogenic substrates that emit light upon reaction with specific enzymes in the presence of the targeted antigen. Enzyme-linked immunosorbent assay (ELISA) kits and instruments are vital in detecting and quantifying cardiac markers. These assays rely on an enzyme-conjugate reaction that produces a measurable colorimetric change. ELISA systems offer flexibility in terms of scalability and are known for their specificity and high sensitivity. Immunochromatography is a rapid and simple diagnostic technique that utilizes the movement of particles along a membrane via capillary action. It involves using antibodies and antigens to detect specific biomarkers, such as cardiac markers. Immunofluorescence is a technique that uses fluorescent dyes or markers to detect the presence of specific antibodies or antigens, and it is employed for more detailed and specific analysis in the context of cardiac markers. Reagents and kits for cardiac marker detection comprise a wide range of immunoassays optimized for various analytical platforms. These consumables often include antibodies, antigens, buffers, and substrates specifically engineered for the qualitative and quantitative assessment of cardiac-specific proteins.

Biomarker Type: High adoption of BNP and NT-proBNP biomarkers for diagnosing and managing heart failure

BNP and NT-proBNP are biomarkers for diagnosing and managing heart failure. BNP is discharged by ventricular myocytes in reaction to increased wall tension, typically due to fluid overload in heart failure. When found at low levels, these peptides have a strong negative predictive value for cardiac risk and heart failure. In contrast, elevated levels are indicative of an increased risk of adverse cardiovascular events. Creatine Kinase-MB (CK-MB) is an isoenzyme of creatine kinase (CK) and is one of the traditional biomarkers for diagnosing myocardial infarction (MI). It is found mainly in cardiac cells and increases in the blood following the death of heart muscle cells. High-sensitivity C-Reactive Protein (Hs-CRP) is an acute-phase protein and a non-specific inflammatory biomarker that can indicate systemic inflammation. It is often used to assess the risk of cardiac disease and other cardiac risk factors. Myoglobin is an early but non-specific marker of myocardial injury. It is most valuable when used alongside more specific cardiac markers, such as troponins, for the early assessment of myocardial infarction. Troponin I and T are regulatory proteins that are part of the cardiac muscle contractile apparatus and are highly specific and sensitive biomarkers for myocardial injury.

End-User: Significant utilization of cardiac marker in laboratory testing facilities

Laboratory testing facilities are typically equipped with sophisticated equipment and skilled personnel capable of performing a comprehensive range of tests. Hospitals and independent diagnostic labs are the primary constituents of this sector. They offer accurate and high-volume cardiac marker testing services, integral for diagnosing various cardiovascular conditions, including myocardial infarctions (heart attacks) and acute coronary syndromes. Point of Care (POC) testing facilities include emergency departments, ambulances, clinics, and physician offices. The immediacy of results allows for swift clinical decision-making, critical in managing cardiac emergencies. POC testing for cardiac markers, such as troponin, BNP (B-type natriuretic peptide), and D-dimer, has revolutionized diagnosing and managing cardiovascular diseases. POCT systems for cardiac markers are designed for simplicity and speed, reducing the turnaround time for decision-making in acute care settings.

Indication: Potential adoption of cardiac markers in congestive heart failure situations

In congestive heart failure (CHF) situations, cardiac markers are crucial in diagnosis, prognosis, and management. B-type natriuretic peptide (BNP) and N-terminal-pro BNP (NT-proBNP) are the primary biomarkers used to confirm suspected CHF, differentiate it from other causes of dyspnea, and assess the severity of the condition. Elevated levels of BNP or NT-proBNP are associated with heart failure, and these markers are used for both diagnosis and monitoring of CHF patients. In myocardial infarction (MI), Troponin I, Troponin T, and creatine kinase-MB (CK-MB) are commonly used cardiac markers for myocardial infarction. Troponins are sensitive and specific markers for detecting myocardial injury. Elevated levels of troponins indicate myocardial infarction and help in diagnosing acute coronary syndrome.

Regional Insights

The Americas has a significant market landscape in the cardiac marker market due to a high prevalence of cardiovascular diseases, well-established healthcare facilities, and major market players. The increasing incidence of heart attacks and the strong focus on early diagnosis and treatment are driving the demand for cardiac marker tests in this region. Moreover, advancements in the biotechnology sector and higher adoption rates for novel diagnostics methodologies contribute to America's cardiac marker market growth. Europe's market growth in the cardiac marker is propelled by the rising aging population, which is more prone to chronic diseases, including coronary heart disease. The availability of cutting-edge healthcare facilities, rising healthcare expenditures, and favorable regulatory policies also support the growth of the European cardiac marker market. Moreover, several key market players and ongoing research activities in the cardiac biomarkers space further stimulate market growth. The Asia-Pacific region is projected to show a significant cardiac marker market growth rate during the forecast period attributed to the large population base, the rising incidences of lifestyle diseases, and the gradual improvement in healthcare infrastructure across emerging economies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiac Marker Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiac Marker Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Marker Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aehealth Limited, Becton, Dickinson and Company, BG Medicine Inc., Bio-Rad Laboratories, Inc., Biomerieux SA, Danaher Corporation, DiaSorin S.P.A., HyTest Ltd., LSI Medience Corporation, PerkinElmer Inc., QuidelOrtho Corporation, Randox Laboratories Ltd., Roche Diagnostics Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Cardiac Marker Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
      • Chemiluminescence
      • ELISA
      • Immunochromatography
      • Immunofluorescence
    • Reagents & Kits
  • Biomarker Type
    • BNP Or NT-ProBNP
    • CK-MB
    • Hs-CRP
    • Myoglobin
    • Troponin I & T
  • End-User
    • Laboratory Testing Facilities
    • Point of Care Testing Facilities
  • Indication
    • Congestive Heart Failure
    • Myocardial Infarction
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cardiac Marker Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiac Marker Market?

3. What are the technology trends and regulatory frameworks in the Cardiac Marker Market?

4. What is the market share of the leading vendors in the Cardiac Marker Market?

5. Which modes and strategic moves are suitable for entering the Cardiac Marker Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing occurrence of cardiovascular diseases
      • 5.1.1.2. Accessibility to a large variety of reagents and kits for cardiac biomarkers
      • 5.1.1.3. Improved healthcare infrastructure and spending across economies
    • 5.1.2. Restraints
      • 5.1.2.1. High prices associated with cardiovascular procedures and solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in cardiac markers
      • 5.1.3.2. Persistent improvement in the essence of point-of-care diagnostic solution
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and approvals for cardiac markers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Reagents and kits provide qualitative and quantitative assessment of cardiac-specific proteins
    • 5.2.2. Biomarker Type: High adoption of BNP and NT-proBNP biomarkers for diagnosing and managing heart failure
    • 5.2.3. End-User: Significant utilization of cardiac marker in laboratory testing facilities
    • 5.2.4. Indication: Potential adoption of cardiac markers in congestive heart failure situations
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cardiac Marker Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Kits

7. Cardiac Marker Market, by Biomarker Type

  • 7.1. Introduction
  • 7.2. BNP Or NT-ProBNP
  • 7.3. CK-MB
  • 7.4. Hs-CRP
  • 7.5. Myoglobin
  • 7.6. Troponin I & T

8. Cardiac Marker Market, by End-User

  • 8.1. Introduction
  • 8.2. Laboratory Testing Facilities
  • 8.3. Point of Care Testing Facilities

9. Cardiac Marker Market, by Indication

  • 9.1. Introduction
  • 9.2. Congestive Heart Failure
  • 9.3. Myocardial Infarction

10. Americas Cardiac Marker Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cardiac Marker Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac Marker Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Mindray Expands Cardiac Biomarker Portfolio with Launch of New Assays
    • 13.3.2. AUDIT MicroControls, Inc. Announces Linearity FLQ Cardiac Markers for Roche Systems
    • 13.3.3. Cipla Launches Diagnostic Device For Multiple Health Conditions
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CARDIAC MARKER MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC MARKER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC MARKER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC MARKER MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CARDIAC MARKER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CARDIAC MARKER MARKET DYNAMICS
  • FIGURE 7. GLOBAL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CARDIAC MARKER MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CARDIAC MARKER MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CARDIAC MARKER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CARDIAC MARKER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CARDIAC MARKER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CARDIAC MARKER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC MARKER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC MARKER MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC MARKER MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC MARKER MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC MARKER MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC MARKER MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC MARKER MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC MARKER MARKET SIZE, BY ELISA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC MARKER MARKET SIZE, BY ELISA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC MARKER MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC MARKER MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC MARKER MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC MARKER MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC MARKER MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC MARKER MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC MARKER MARKET SIZE, BY BNP OR NT-PROBNP, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC MARKER MARKET SIZE, BY BNP OR NT-PROBNP, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC MARKER MARKET SIZE, BY CK-MB, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC MARKER MARKET SIZE, BY CK-MB, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC MARKER MARKET SIZE, BY HS-CRP, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC MARKER MARKET SIZE, BY HS-CRP, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC MARKER MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC MARKER MARKET SIZE, BY MYOGLOBIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC MARKER MARKET SIZE, BY TROPONIN I & T, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC MARKER MARKET SIZE, BY TROPONIN I & T, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC MARKER MARKET SIZE, BY LABORATORY TESTING FACILITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC MARKER MARKET SIZE, BY LABORATORY TESTING FACILITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC MARKER MARKET SIZE, BY POINT OF CARE TESTING FACILITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC MARKER MARKET SIZE, BY POINT OF CARE TESTING FACILITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC MARKER MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC MARKER MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC MARKER MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC MARKER MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CARDIAC MARKER MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES CARDIAC MARKER MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 347. NORWAY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 348. NORWAY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 355. POLAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 356. POLAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 357. POLAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 358. POLAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 365. QATAR CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 366. QATAR CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 367. QATAR CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 368. QATAR CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 369. QATAR CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 370. QATAR CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 371. QATAR CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 372. QATAR CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 373. QATAR CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 374. QATAR CARDIAC MARKER